AXSM - Wall Street Estimates - Axsome Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 108.9718

0.112 %

$ 5.28 B

Market Cap

-16.56

P/E

Price Target Average

14.71%

Revenue Forecast Estimate

94.91%

EBIT Estimate

58.43%

Net Income Estimate

68.49%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Axsome Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for AXSM of $125 , with forecasts ranging from a low of $106 to a high of $180 .

AXSM Lowest Price Target Wall Street Target

106 USD -2.73%

AXSM Average Price Target Wall Street Target

125 USD 14.71%

AXSM Highest Price Target Wall Street Target

180 USD 65.18%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free